Description
Summary:
Describes a method for determining the titer of viable Poliomyelitis virus through the enumeration of plaques formed on a monolayer of sensitive target cells. Intended for use in routine testing of cell lines, cell line derived products and for the support of process validations of systems that claim to remove or inactivate Poliomyelitis virus.
Included Sections:
Purpose, Scope, Responsibility, References and Applicable Documents, Materials and Equipment, Health and Safety Considerations, Documentation Requirements, and Procedures
Included Attachments/Appendices:
None
About This Document:
This is not a generic template, it's a 6-page procedure that was actually created and used in the Bioprocessing operations of a FDA-regulated establishment. The company-specific information (names, addresses, some images, proprietary product information, etc.) has been redacted but the content and format have been largely preserved.
Reasons to Buy:
- Use it as a starting point for your own documentation project
- Compare the quality of your documents against your industry peers
- Learn what other companies in your industry are actually doing
Who Will Benefit:
- Biologic Manufacturing Personnel
- Process Development Personnel
- Method Development Personnel
Product Details
- Edition:
- 2
- Published:
- 08/01/2007
- Number of Pages:
- 6
- File Size:
- 1 file , 350 KB
